RxDoctor Payments Data

Michael Isakoff

Pediatric Hematology-Oncology · Hartford, CTNPI 1982678595

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,964 of the $8,144 with a category attached, or 97.8%. 7 manufacturers reported payments, led by Y-mabs Therapeutics, Inc. at 42.4% of the total. Reporting peaked in 2022 at $7,086 and has fallen 98.0% since, to $144 in 2023.

$8,144in general payments, 2019–2025

Across 11 payments — averaging $740.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Y-mabs Therapeutics, Inc.$3K
  • Regeneron$3K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Bayer$900
  • USWM, LLC$72
  • Fennec Pharmaceuticals, Inc.$72
  • plus $36 from 1 others
$635,045in research payments, 2019–2025

Across 92 payments — averaging $6902.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$507K
  • E.r. Squibb & Sons, L.L.C.$55K
  • Pfizer$40K
  • Incyte Corporation$19K
  • Merck$14K

What the payments were for

  • Consulting fees$7,96498%
  • Food & beverage$1802%

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →